Carnegie acted as joint global co-ordinator and joint bookrunner in the SEK 1,633m rights issue in Vimian.
Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services.